Albino Lifesciences Private Limited, a active private limited company, was established on 26 April 1991 in Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74899DL1991PTC044094. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.30 Cr and a paid-up capital of ₹2.57 Cr.
Formerly known as Impex Pharma Private Limited. It upholds a compliant status. Employing 22 professional, Its leadership includes Dinesh Mohan Daga (Managing Director), Sugandha Daga (Director). Past directors included Madhu Daga, Abhay Daga. It holds ₹62.21 Cr open charges and ₹29.57 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at M-64, Basement Lajpat Nagar Ii India, New Delhi, Delhi, 110024.
U74899DL1991PTC044094
044094
26 April 1991
₹5.30 Cr
₹2.57 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Albino Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Mohan Daga | Managing Director | 26 Apr 1991 | Current |
| Sugandha Daga | Director | 07 Feb 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2007 | Past |
| Pramod Abcsdd | Director | 06 Jul 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Albino Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Albino Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹622,100,000.00
₹295,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2024 | State Bank Of India | ₹40.00 Cr | Open |
| 13 Jun 2023 | Others | ₹15.21 Cr | Open |
| 09 Dec 2021 | Others | ₹2.00 Cr | Open |
| 28 Aug 2020 | Axis Bank Limited | ₹5.00 Cr | Open |
| 27 Apr 2022 | Axis Bank Limited | ₹7.45 Cr | Satisfied |
Explore comprehensive loan charge details -
Albino Lifesciences has a workforce of 22 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Albino Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albino Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India of Rs. 40.00 Cr registered on 21 Feb 2024 with Charge ID 100881372 was modified on 29 Jan 2025. was documented.
Albino Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Axis Bank Limited of Rs. 5.00 Cr registered on 28 Aug 2020 with Charge ID 100389005 was modified on 11 Jun 2024. was documented.
Progress on A charge with Others of Rs. 15.21 Cr registered on 13 Jun 2023 with Charge ID 100730640 was modified on 04 May 2024. was documented.
The activity Albino Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with State Bank Of India amounted to Rs. 40.00 Cr with Charge ID 100881372 was registered on 21 Feb 2024. was recorded as a recent event.
The CIN of Albino Lifesciences Private Limited is U74899DL1991PTC044094.
Albino Lifesciences Private Limited is headquartered at M-64, Basement Lajpat Nagar Ii India, New Delhi, Delhi, 110024.
Albino Lifesciences Private Limited was incorporated on 26 April 1991.
The current directors of Albino Lifesciences Private Limited are
The primary industry of Albino Lifesciences Private Limited is Trade.
Albino Lifesciences Private Limited is unlisted.
The authorized capital of Albino Lifesciences Private Limited is ₹5.30 Cr, and the paid-up capital is ₹2.57 Cr.
The compliance status of Albino Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX